Effects of fidarestat, an aldose reductase inhibitor, on nerve conduction velocity and bladder function in streptozotocin-treated female rats

Journal of Diabetes and its Complications

Volumn 21, Issue 3, 2007, Pages 187-195

  Zotova, Elena G ^a   Christ, George J ^b   Zhao, Weixin ^b   Tar, Moses ^a   Kuppam, Srini D ^a   Arezzo, Joseph C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetic cystopathy; Diabetic peripheral neuropathy; Fidarestat; High frequency repetitive stimulation; STZ induced diabetes

Indexed keywords

FIDARESTAT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER FUNCTION; CONTROLLED STUDY; CYSTOMETRY; DIABETIC AUTONOMIC NEUROPATHY; DIABETIC NEUROPATHY; DIABETIC SOMATIC NEUROPATHY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; HYPERGLYCEMIA; MICTURITION; NERVE CONDUCTION; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; URINARY FREQUENCY;

ALDEHYDE REDUCTASE; ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HYPERGLYCEMIA; IMIDAZOLIDINES; NEURAL CONDUCTION; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER; URINATION;

EID: 34247595874     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.10.001     Document Type: Article

References (63)

1. Abbate S.L., Atkinson M.B., and Breuer A.C. Amount and speed of fast axonal transport. Diabetes 40 (1991) 111-117
2. Alloussi S., Mast G.J., Kopper B., and Ziegler M. Micturition disorder as a sequela of sacral autonomic diabetic neuropathy. Urologe A 24 (1985) 291-295
3. Apfel S.C. Neurotrophic factors in the therapy of diabetic neuropathy. European Neurology 41 (1999) 27-34
4. Apfel S.C., Arezzo J.C., Brownlee M., Federoff H., and Kessler J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Research 634 (1994) 7-12
5. 1c and induced sorbitol suppression. International Polyol Pathway Conference, Hawaii (2004)
6. Arezzo J.C., and Zotova E. Electrophysiologic measures of diabetic neuropathy: Mechanism and meaning. In: Tomlinson D. (Ed). Neurobiology of diabetic neuropathy. International Review of Neurobiology Vol. 50 (2002), Academic Press, New York 230-255
7. Bianchi R., Triban C., Marini P., Figliomeni B., Paro M., Italiano G., Prosdocimi M., and Fiori M.G. Inner ester derivatives of gangliosides protect autonomic nerves of alloxan diabetic rats against Na+,K(+)-ATPase activity defects. Diabetes Research and Clinical Practice 12 (1991) 107-111
8. Boulton A.J.M., Arezzo J.C., Malik R.A., and Sosenko J.M. Diabetic somatic neuropathies. Diabetes Care 27 (2004) 1458-1486
9. Brown J., Posner S., and Stewart A. Urge incontinence: New health-related quality of life measures. Journal of the American Geriatrics Society 47 (1999) 980-988
10. Brown J., Seeley D., Fong J., Black D., Ensrud K., and Grady D. Urinary incontinence in older women: Who is at risk?. Obstetrics and Gynecology 87 (1996) 715-721
11. Brown J.S., Nyberg L.M., Kusek J.W., Burgio K.L., Diokno A.C., Foldspang A., Fultz N.H., Herzog A.R., Hunskaar S., Milsom I., Nygaard I., Subak L.L., and Thom D.H. National Institute of Diabetes and Digestive Kidney Diseases International Research Working Group on Bladder Dysfunction. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on epidemiologic issues in urinary incontinence in women. American Journal of Obstetrics and Gynecology 188 (2003) S77-S88
12. Brown J.S., Subak L.L., Gras J., Brown B.A., Kuppermann M., and Posner S.F. Urge incontinence: The patient's perspective. Journal of Women's Health 7 (1998) 1263-1269
13. Brown J.S., Wessels H., Chancellor M.B., Howards S.S., Stamm W.E., Stapleton A.E., Steers W.D., Van Den Eeden S.K., and McVary K.T. Urologic complications of diabetes. Diabetes Care 28 (2005) 177-185
14. Calcutt N.A., Dines K.C., and Ceseña R.M. Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism 47 (1998) 650-656
15. Cameron N.E., Cotter M.A., Jack A.M., Basso M.D., and Hohman T.C. Protein kinase C effects on nerve function, perfusion, Na(+),K(+)-ATPase activity and glutathione content in diabetic rats. Diabetologia 42 (1999) 1120-1130
16. Christ G.J., Day N.S., Day M., Santizo C., Zhao W., Sclafani T., Zinman J., Hsieh K., Venkateswarlu K., Valcic M., and Melman A. Bladder injection of "naked" hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 281 (2001) R1699
17. Christ G.J., Day N.S., Day M., Zhao W., Persson K., Pandita R.K., and Andersson K.E. Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo. American Journal of Physiology. Regulatory, Integrative and Comparative physiology 284 (2003) R1241-R1248
18. Dall'Ago P., Silva V.O., DeAngelis K.L., Irigoyen M.C., Fazan Jr. R., and Salgado H.C. Reflex control of arterial pressure and heart rate in short-term streptozotocin diabetic rats. Brazilian Journal of Medical and Biological Research 35 (2002) 843-849
19. Diokno A.C., Brock B.M., Herzog A.R., and Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology 36 (1990) 129-138
20. Djemli-Shipkolye A., Coste T., Raccah D., Vague P., Pieroni G., and Gerbe A. Na,K-Atpase alterations in diabetic rats: Relationship with lipid metabolism and nerve physiological parameters. Cellular and Molecular Biology (Noisy-le-Grand, France) 47 (2001) 297-304
21. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Annals of Internal Medicine 92 (1980) 321-323
22. Engelgau M.M., Narayan K.M., Saaddine J.B., and Vinicor F. Addressing the burden of diabetes in the 21st century: Better care and primary prevention. Journal of the American Society of Nephrology 14 (2003) S88-S91
23. Faerman I., Maler M., Jadzinsky M., Alvarez E., Fox D., Zilbervarb J., Cibeira J.B., and Colonas R. Asymptomatic neurogenic bladder in juvenile diabetics. Diabetologia 7 (1971) 168-172
24. Frimodt-Moller C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Danish Medical Bulletin 25 (1978) 49-60
25. Frimodt-Moller C., and Mortensen S. Treatment of diabetic cystopathy. Annals Internal Medicine 92 (1980) 327-328
26. Green A., Jaspan J., Kavin H., Chung S., and Schoenberg H. Influence of long-term aldose reductase inhibitor therapy on autonomic dysfunction of urinary bladder, stomach and cardiovascular systems in diabetic patients. Diabetes Research and Clinical Practice 4 (1987) 67-75
27. Hellweg R., and Hartung H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. Journal of Neuroscience Research 26 (1990) 258-267
28. Hirata Y., and Okada K. Relation of Na+,K(+)-ATPase to delayed motor conduction velocity: Effect of aldose reductase inhibitor, AND-138, on Na+,K(+)-ATPase activity. Metabolism 39 (1990) 563-567
29. Hohman T.C., Cotter M.A., and Cameron N.E. ATP-sensitive K(+) channel effects on nerve function, Na(+),K(+) ATPase, and glutathione in diabetic rats. European Journal of Pharmacology 397 (2000) 335-341
30. Hotta N., Toyota T., Matsuoka K., Shigeta Y., Kikkawa R., Kaneko T., Takahashi A., Sugimura K., Koike Y., Ishii J., and Sakamoto N. The SNK-860 Diabetic Neuropathy Study Group. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 24 (2001) 1776-1782
31. Jackson R.A., Vittinghoff E., Kanaya A.M., Miles T.P., Resnick H.E., Kritchevsky S.B., Simonsick E.M., and Brown J.S. Urinary incontinence in elderly women: Findings from the health, aging, and body composition study. Obstetrics and Gynecology 104 (2004) 301-307
32. Kann O., Schuchmann S., Buchheim K., and Heinemann U. Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience 119 (2003) 87-100
33. Kato N., Mizuno K., Makino M., Nakano K., Suzuki T., and Yagihashi S. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats. Diabetes Research and Clinical Practice 50 (2000) 77-85
34. Kato N., Mizuno K., Matsubara A., Nakano K., Kurono M., and Yagihashi S. Effect of long-term treatment with new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats. Journal of Diabetes and its Complications 8 (1994) 27-32
35. Kato N., Yashima S., Suzuki T., Nakayama Y., and Jomori T. Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. Journal of Diabetes and its Complications 17 (2003) 374-379
36. Lee P.G., Hohman T.C., Cai F., Regalia J., and Helke C.J. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in cervical vagus nerve. Experimental Neurology 170 (2001) 149-161
37. Marks J.B., and Raskin P. Cardiovascular risk in diabetes. A brief review. Journal of Diabetes and its Complications 14 (2000) 108-115
38. McVary K.T., Rathnau C.H., and McKenna K.E. Sexual dysfunction in the diabetic BB/WOR rat: A role of central neuropathy. American Journal of Physiology 272 (1997) R259-R267
39. Menendez V., Cofan F., Talbot-Wright R., Ricart J., Gutierrez R., and Carretero P. Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease. Journal of Urology 155 (1996) 2001-2004
40. Mitsui T., Kakizaki H., Kobayashi S., Morita H., Matsumura K., and Koyanagi T. Vesicourethral function in diabetic patients: Association of abnormal nerve conduction velocity with vesicourethral dysfunction. Neurourology and Urodynamics 18 (1999) 639-645
41. Mizuno K., Kato N., Makino M., Suzuki M., and Shindo M. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy. Journal of Diabetes and its Complications 13 (1999) 141-150
42. Mizuno K., Kato N., Matsubara A., Nakato K., and Kuruno M. Effects of new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Metabolism 41 (1992) 1081-1086
43. Nadelhaft I., and Vera P.L. Reduced urinary bladder afferent conduction velocities in streptozocin diabetic rats. Neuroscience Letters 135 (1992) 276-278
44. Oates P.J. Polyol pathway and diabetic peripheral neuropathy. In: Tomlinson D. (Ed). International review of neurobiology. Neurobiology of Diabetic Neuropathy Vol. 50 (2002), Academic Press, New York 326-377
45. Obrosova I.G., Minchenko A.G., Vasupuram R., White L., Abaton O.I., Kumagai A.K., Frank R.N., and Stevens M.J. Aldose-reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 53 (2003) 864-871
46. Paro M., Italiano G., Travagli R.A., Petrelli L., Zanoni R., Prodosdocimi M., and Fiori M.G. Cystometric changes in alloxan diabetic rats: Evidence for functional and structural correlates of diabetic autonomic neuropathy. Journal of the Autonomic Nervous System 30 (1990) 1-11
47. Paro M., Prashar A., Prodosdocimi M., Cherian P.V., Fiori M.G., and Sima A.A. Urinary bladder dysfunction in the BB/W diabetic rat: Effect of ganglioside treatment on functional and structural alterations. Journal of Urology 151 (1994) 781-786
48. Salinas C.J., Virseda C.M., Adot Z.J.M., Teba del Pino F., Arredondo M.F., Hernandez L.A., Fernandez L.C., and Herrero P.A. Diabetic neurocystopathy: Multivariate study. Archivos Espanoles de Urologia 52 (1999) 149-156
49. Sasaki K., Chancellor M.B., Goins W.F., Phelan M.W., Glorioso J.C., de Groat W.C., and Yoshimura N. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53 (2004) 2723-2730
50. Sasaki K., Yoshimura N., and Chancellor M.B. Implications of diabetes mellitus in urology. Urologic Clinics of North America 30 1 (2003) 1-12
51. Schmidt R.E. Neuropathology and pathogenesis of diabetic autonomic neuropathy. In: Tomlinson D. (Ed). International Review of Neurobiology. Neurobiology of Diabetic Neuropathy Vol. 50 (2002), Academic Press, New York 230-255
52. Schmidt R.E., Dorsey D.A., Beaudet L.N., Parvin C.A., Zhang W., and Sima A.F. Experimental rat models of type 1 and type 2 diabetes in sympathetic neuroaxonal dystrophy. Journal of Neuropathology and Experimental Neurology 63 (2004) 450-460
53. Starer P., and Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Archives of Internal Medicine 150 (1990) 810-813
54. Steers W.D., Mackway A.M., Ciambotti J., and DeGroat W.C. Effects of streptozotocin-induced diabetes on bladder function in the rat. Journal of Urology 143 (1990) 1032-1036
55. Toyry J.P., Partanen J.V., Nishanen L.K., Lansimies E.A., and Uusitupa M.I. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 40 (1997) 953-958
56. Ueda T., Tamaki M., Kageyama S., Yoshimura N., and Yoshida O. Urinary incontinence among community-dwelling people aged 40 years or older in Japan: Prevalence, risk factors, knowledge and self-perception. International Journal of Urology 7 (2000) 95-103
57. Ueda T., Yoshimura N., and Yoshida O. Diabetic cystopathy: Relationship to autonomic neuropathy detected by sympathetic skin response. Journal of Urology 157 (1997) 580-584
58. Vinik A.I., Maser R.E., Mitchell B.D., and Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1553-1579
59. Watanabe T., and Miyagawa I. Effect of long-chain fatty alcohol on peripheral nerve conduction and bladder function in diabetic rats. Life Sciences 70 (2002) 2215-2224
60. Wetle T., Scherr P., Branch L.G., Resnick N.M., Harris T., Evans D., and Taylor J.O. Difficulty with holding urine among older persons in a geographically defined community: Prevalence and correlates. Journal of the American Geriatrics Society 43 (1995) 349-455
61. Woodman S.E., Cheung M.W., Tarr M., North A.C., Schubert W., Lagaud G., Marks C.B., Russell R.G., Hassan G.S., Factor S.M., Christ G.J., and Lisanti M.P. Urogenital alterations in aged male caveolin-1 knockout mice. Journal of Urology 171 (2004) 950-957
62. Yagihashi S., and Sima A.A. Neuroaxonal and dendritic dystrophy in diabetic autonomic neuropathy. Classification and topographic distribution in the BB-rat. Journal of Neuropathology and Experimental Neurology 45 (1986) 545-565
63. Yamazaki Y., Karakida T., and Homma S. Conduction velocity of motor nerve and cervical sympathetic and vagus nerve in streptozotocin diabetic rats. Neuroscience Letters 113 (1990) 29-33